Minimally invasive neuronavigator-guided microsurgery and photodynamic therapy for gliomas

Abstract

In order to evaluate the effectiveness of neuronavigator-guided microsurgery and keyhole technique for the resection of gliomas, a total of 60 patients with gliomas were exactly located by using neuronavigator during microsurgery. Forty deep-seated gliomas were resected through a keyhole operative approach. Thirty out of the 60 cases were subjected to photodynamic therapy (PDT) after tumor resection. The therapeutic effectiveness of all the cases was recorded and analyzed. The results showed that glioma was totally resected in 52 cases (86.7%), subtotally in 5 (8.3%), and most partially in 3 (5%). Neurological deficits occurred postoperatively in 4 cases. One patient died of multiple system organ failure 4 days after operation. It was concluded that the application of minimally invasive technique could dramatically decrease surgical complications following resection of glioma, and its combination with PDT could obviously improve the quality of life of patients and prolong the survival time.

Keywords

neuronavigation / keyhole surgery / glioma / photodynamic therapy

References

[1] StadieA.T., ReischR., KockroR.A., et al.. Minimally invasive cerebral cavernoma surgery using keyhole approaches — solutions for technique-related limitations. Minim Invasive Neurosurg, 2009, 52: 9-16

[2] LanQ., DongJ., HuangQ.. Minimally invasive keyhole approaches for removal of tumors of the third ventricle. Chin Med J, 2006, 119: 1444-1450

[3] RobertsD.W., StrohbehnJ.W., HatchJ.F., et al.. A frameless stereotaxic integration of computerized tomographic imaging and the operating microscope. J Neurosurg, 1986, 65: 545-549

[4] WatanabeE., WatanabeT., ManakaS., et al.. Three-dimensional digitizer (neuronavigator): new equipment for computed tomography-guided stereotaxic surgery. Surg Neurol, 1987, 27: 543-547

[5] GrunertP., HopfN., PerneczkyA.. Frame-based and frameless endoscopic procedures in the third ventricle. Stereotact Funct Neurosurg, 1997, 68: 80-89

[6] KalbarczykA., KraussJ.K., SeilerR.W.. Endoscopic stereotactic surgery for intraventricular loculated empyema: Case report. Surg Neurol, 1999, 52: 412-417

[7] RohdeV., ReingesM.H., KrombachG.A., et al.. The combined use of image-guided frameless stereotaxy and neuroendoscopy for the surgical management of occlusive hydrocephalus and intracranial cysts. Br J Neurosurg, 1998, 12: 531-538

[8] HorvathZ., VetoF., BalasI., et al.. Complete removal of colloid cyst via CT-guided stereotactic biportal neuroendoscopy. Acta Neurochir (Wien), 2000, 142: 539-545

[9] KimI.Y., JungS., MoonK.S., et al.. Neuronavigation-guided endoscopic surgery for pineal tumors with hydrocephalus. Minim Invas Neurosurg, 2004, 47: 365-368

[10] DuG.H., ZhouL.F., MaoY.. Neuronavigator-guided glioma surgery. CMJ (Chinese), 2003, 114: 1484-1487

[11] DiX.. Multiple brain tumor nodule resections under direct visualization of a neuronavigated endoscope. Minim Invasive Neurosurg, 2007, 50: 227-232

[12] MaciunasR.J.. Computer-assisted neurosurgery. Clin Neurosurg, 2006, 53: 267-271

[13] KostronH., RösslerK.. Surgical intervention in patients with malignant glioma. Wien Med Wochenschr, 2006, 156: 338-341

[14] WillemsP.W., van der SprenkelJ.W., TullekenC.A., et al.. Neuronavigation and surgery of intracerebral tumours. J Neurol, 2006, 253: 1123-1136

[15] MoriokaJ., NishizakiT., TokumaruT., et al.. Functional magnetic resonance imaging-controlled neuronavigator-guided brain surgery: a case report. J Clin Neurosci, 2001, 8: 283-285

[16] UnsgardG., OmmedalS., MullerT., et al.. Neuronavigation by intraoperative three dimensional ultrasound: initial experience during brain tumor resection. Neurosurgery, 2002, 50: 804-812

[17] WalkerM.D., AlexanderE.Jr, HuntW.E., et al.. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial. J Neurosurg, 1978, 49: 333-343

[18] SengerD., CairncrossJ.G., ForsythP.A.. Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype?. Cancer J, 2003, 9: 214-221

[19] WallnerK.E., GalicichJ.H., KrolG., et al.. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys, 1989, 16: 1405-1409

[20] BrownS.B., BrownE.A., WalkerI.. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol, 2004, 5: 497-508

[21] AllisonR.R., DownieG.H., CuencaR., et al.. Photosensitizers in clinical PDT. Photodiagnosis Photodyn Ther, 2004, 1: 27-42

[22] CarpentierA.C.. Surgical resection of gliomas in 2008. Cancer Radiother, 2008, 12: 676-686

[23] RitzR., MüllerM., DietzK., et al.. Hypericin uptake: a prognostic marker for survival in high-grade glioma. J Clin Neurosci, 2008, 5: 778-783